The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCPT.L Regulatory News (CPT)

  • There is currently no data for CPT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Proposed Settlement of Director Debt

30 Jun 2015 11:21

RNS Number : 6566R
Frontier Resources International
30 June 2015
 

For immediate release

 

30 June 2015

 

Frontier Resources International Plc

("Frontier" or the "Company")

Proposed Settlement of Director Debt

 

The Directors, in their continuing support of the Group's business needs, had previously agreed to continue the deferral of a proportion of their remuneration until at least 1 January 2015, an extension of three months from 1 October 2014 agreed at the time of admission to AIM.

 

As previously announced in April, as at 28 February 2015, a total of £395,557 was due by the Company to Mr Keyes (comprising £257,540 deferred salary payments due under his service agreement and £138,017 due under the Director's current account) and £40,000 was due by the Company to Mrs Spurrier in respect of accrued but unpaid remuneration. In aggregate the amount owed by the Company to Mr Keyes and Mrs Spurrier amounted to £435,557 (the "Director Debt") at that time. The Company had agreed to settle the Director Debt on completion of the subscription for new Ordinary Shares by AGR Energy Limited No. II ("AGR").

 

Notwithstanding that the AGR subscription did not subsequently proceed, Mr Keyes and Mrs Spurrier and the Company have agreed that it would be in the Company's best interests for the Director Debt to be settled on substantially the same terms, save that the cash payment previously to be paid to Mr Keyes and Mrs Spurrier will be deferred and the number of new Ordinary Shares to be issued will be determined by using the issue price of the next fund raising by the Company.

 

Accordingly, £54,444.63 of the Director Debt will be settled at the next fund raising by the issue of new Ordinary Shares (at the then funding issue price). In respect of the balance of the Director Debt of £381,112.38, an amount of £108,889.25 will be written-off immediately and the remaining balance of £272,223.13 will be paid only in the event that the Company completes a farm-out of its interests in one or more of its projects which involves the reimbursement to the Company of at least £435,556 of historic exploration expenditure.

The proposed settlement is being treated as related party transaction for the purposes of Rule 13 of the AIM Rules. Accordingly the Independent Directors, being Neil Herbert and John O'Donovan, having consulted with the Company's nominated adviser, consider that the proposed settlement of the Director Debt is fair and reasonable insofar as the Company's shareholders are concerned. The Independent Directors have taken into account in particular the quantum of the Director Debt being written-off immediately, the amount being deferred until such time as the Company completes a farm-out and that the new Ordinary Shares to be issued will be at a price determined in the next public funding by the Company.

 

Enquiries:

 

Frontier Resources International Plc

Jack Keyes, Chief Executive Officer

Neil Herbert, Chairman

 

Tel: +1 (281) 920 0061

Tel: +44 (0) 020 3475 8108

 

Beaumont Cornish Limited (Nomad)

Michael Cornish

Roland Cornish

 

Tel: +44 (0)20 7628 3396

 

Beaufort Securities Limited (Broker)

Saif Janjua

 

 

Tel: +44 (0)20 7382 8300

 

A copy of this announcement is available from the Company's website www.friplc.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLLFFIRIIIVIE
Date   Source Headline
2nd Dec 20204:25 pmRNSChange of name to MyHealthChecked Plc
2nd Dec 202011:06 amRNSSecond Price Monitoring Extn
2nd Dec 202011:01 amRNSPrice Monitoring Extension
2nd Dec 20207:00 amRNSGenomic testing service launch and Change of name
24th Nov 20204:41 pmRNSSecond Price Monitoring Extn
24th Nov 20204:36 pmRNSPrice Monitoring Extension
23rd Nov 20207:00 amRNSAcquisition of home-use genetic testing company
28th Sep 20207:00 amRNSHalf-year Report
22nd Jul 20207:00 amRNSChange of Adviser
6th Jul 20207:00 amRNSCommercial update; Change of registered office
2nd Jul 20203:24 pmRNSResult of AGM
5th Jun 20207:01 amRNSDirector/PDMR Shareholding
5th Jun 20207:00 amRNSNotice of Annual General Meeting
2nd Jun 20207:00 amRNSCommercial update
29th May 20207:00 amRNSFinal Results
4th May 20207:00 amRNSPartnership agreement with Abingdon Health
27th Apr 20208:16 amRNSDirector/PDMR Shareholding
24th Apr 202011:26 amRNSResult of GM & Completion of Fundraise
14th Apr 20209:27 amRNSHolding(s) in Company
14th Apr 20207:00 amRNSManufacturing outsourcing agreements for myLotus®
8th Apr 20207:00 amRNSPlacing and Subscription to raise £1.9 million
29th Jan 20207:00 amRNSTrading Update
14th Nov 20197:00 amRNSBoard Appointments
13th Nov 20198:35 amRNSBoard changes - replacement
13th Nov 20197:00 amRNSBoard Changes
31st Oct 20197:00 amRNSConcepta announces first myLotus® UK birth
25th Oct 20197:00 amRNSBoard Changes
30th Sep 20197:00 amRNSInterim Results
30th Sep 20197:00 amRNSFirst myLotus® UK Fertility Clinic collaboration
29th Jul 20197:00 amRNSGrant of Options
9th Jul 20197:00 amRNSmyLotus® pregnancies in double figures
13th Jun 20192:01 pmRNSResult of AGM
21st May 20199:00 amRNSNotice of AGM
14th May 20197:01 amRNSAnnual Results
14th May 20197:00 amRNSConcepta announces first myLotus® pregnancies
30th Apr 20194:28 pmRNSHolding(s) in Company
30th Apr 20191:46 pmRNSTR-1: form for notification of major holdings
29th Apr 20191:20 pmRNSTR-1: notification of major holdings
26th Apr 201910:52 amRNSDirector/PDMR Shareholding
8th Apr 20197:00 amRNSPlacing to raise £2.3m; Notice of General Meeting
29th Mar 20197:00 amRNSConcepta to supply myLotus® to Boots UK
12th Mar 20197:00 amRNSConcepta to supply myLotus® to Walgreens Boots
17th Dec 20187:00 amRNSmyLotus® successful UK launch
31st Oct 20187:00 amRNSmyLotus® launch at The Fertility Show, London
29th Oct 20187:00 amRNSmyLotus gains CE-mark regulatory approval
5th Oct 20182:42 pmRNSHolding(s) in Company
28th Sep 20187:00 amRNSGrant of Options
27th Sep 20184:41 pmRNSSecond Price Monitoring Extn
27th Sep 20184:37 pmRNSPrice Monitoring Extension
27th Sep 20187:01 amRNSDirectorate change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.